Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.230
+0.060 (2.76%)
At close: Feb 2, 2026, 4:00 PM EST
2.170
-0.060 (-2.69%)
Pre-market: Feb 3, 2026, 5:38 AM EST

Clearmind Medicine Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
34621022
Market Cap Growth
-49.80%-22.88%216.02%-82.88%-53.16%-
Enterprise Value
-01-2-21017
Last Close Price
2.2331.8255.60146.289480.0121344.46
PB Ratio
0.303.651.811.81-9.425.74
P/TBV Ratio
3.053.971.882.07-5.99
Debt / Equity Ratio
1.491.490.02--0.04-
Quick Ratio
1.211.211.711.160.2213.33
Current Ratio
1.221.221.721.170.2313.78
Return on Equity (ROE)
-179.39%-179.39%-256.89%--570.96%-145.26%
Return on Assets (ROA)
-53.11%-53.11%-54.37%-116.22%-169.53%-83.90%
Return on Capital Employed (ROCE)
-475.20%-475.20%-183.90%-640.90%565.20%-76.80%
Earnings Yield
-115.32%-88.70%-93.20%-483.18%-66.18%-13.49%
FCF Yield
-141.56%-108.88%-86.17%-353.19%-35.80%-10.40%
Buyback Yield / Dilution
-63.98%-63.98%----
Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q